Press releases | WebDisclosure

Basculer en Français

10443	Companies
219242	Keywords
148699	Articles
115971	Press releases

Home
Press releases

PRESS RELEASE

published on 01/10/2025 at 00:00, 1 year 4 months ago

MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
MedMira Inc. receives Health Canada authorization for clinical trials of Multiplo® Complete Syphilis Antibody Test. Innovative solution for active and past syphilis cases

Clinical Trials MedMira Inc. Health Canada Syphilis Diagnostic Tool
PRESS RELEASE

published on 01/09/2025 at 23:05, 1 year 4 months ago

Caldwell Reports First Quarter Results
Talent acquisition firm Caldwell Partners Int'l Inc. (TSX:CWL)(OTCQX:CWLPF) reports Q1 fiscal 2025 financial results showing growth in professional fees and stable operations

Financial Results Talent Acquisition Growth Caldwell Partners Professional Fees
PRESS RELEASE

published on 01/09/2025 at 22:45, 1 year 4 months ago

Onco-Innovations' Technology Shown in Study to Successfully Inactivate DNA Repair in Cancer, Potentially Boosting Radiation Therapy Effectiveness
Onco-Innovations Limited announces exclusive PNKP inhibitors Technology for cancer treatment, potentially improving patient outcomes

Technology Patient Outcomes Cancer Treatment PNKP Inhibitors Onco-Innovations Limited
PRESS RELEASE

published on 01/09/2025 at 22:00, 1 year 4 months ago

Vision Marine Technologies Innovates HV Marine Battery Packs in Collaboration With Calip Group
Vision Marine Technologies partners with Calip Group to establish a production line for custom cooling plates tailored for high-voltage marine battery packs. The collaboration aims to enhance thermal management and extend battery lifespan

Vision Marine Technologies Thermal Management Calip Group Custom Cooling Plates High-voltage Marine Battery Packs
PRESS RELEASE

published on 01/09/2025 at 21:00, 1 year 4 months ago

CAGE Bio Announces Phase 2b Trial for CGB-500 (1% Tofacitinib), a Breakthrough Topical JAK Inhibitor for Moderate to Severe Atopic Dermatitis
CAGE Bio initiates Phase 2b trial for CGB-500, a topical JAK inhibitor ointment for atopic dermatitis. High efficacy, low side-effects. Improving patient outcomes

Phase 2B Trial Atopic Dermatitis CAGE Bio CGB-500 Topical Therapy
PRESS RELEASE

published on 01/09/2025 at 20:30, 1 year 4 months ago

Energy Northwest and EVCS to Boost Electric Vehicle Charging Along Highway 101
Energy Northwest and EVCS collaborate to install 40 DC Fast chargers along Highway 101 in rural Washington and Oregon, supported by a $14.6M grant. Project aims to enhance EV infrastructure on the US West Coast

Grant DC Fast Chargers EV Infrastructure EVCS Energy Northwest
PRESS RELEASE

published on 01/09/2025 at 20:28, 1 year 4 months ago

EQS-Adhoc: DATAGROUP will not pursue the spin-off of its subsidiary Almato AG
DATAGROUP SE decides not to pursue the spin-off of Almato AG, citing uncertainties in achieving planned advantages. The company will focus on the development of Almato internally

Shareholder Value DATAGROUP SE Strategic Decision Spin-off Almato AG
PRESS RELEASE

published on 01/09/2025 at 20:20, 1 year 4 months ago

EQS-Adhoc: Shelly Group announces preliminary consolidated sales revenues FY 2024
Shelly Group SE announces 43% increase in consolidated sales revenues for FY 2024 to approximately EUR 107 million, slightly exceeding forecast. EBIT forecast for 2024 confirmed, revenue target for 2026 unchanged

Revenue Forecast EBIT FY 2024 Shelly Group SE Consolidated Sales Revenues
PRESS RELEASE

published on 01/09/2025 at 20:02, 1 year 4 months ago

Ur-Energy Will Participate in the "2025 Mining Conference: Mining & Supplying Critical Minerals & Precious Metals" Presented by Maxim Group LLC on Thursday, January 16
Ur-Energy CEO John Cash to participate in 2025 Mining Conference hosted by Maxim Group LLC. Focus on critical minerals and precious metals. Conference to be held virtually

Critical Minerals Precious Metals Mining Conference Ur-Energy Maxim Group
REGULATED PRESS RELEASE

published on 01/09/2025 at 19:03, 1 year 4 months ago

ALTAREIT : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE
Bilan semestriel du contrat de liquidité d'Altareit avec Rothschild Martin Maurel : transactions et volume échangé au 2nd semestre 2024 conformément aux pratiques de marché admises

Rothschild Martin Maurel Transactions ALTAREIT Liquidité Volume

Accesswire

Published on 05/23/2026 at 03:15, 16 hours 23 minutes ago

UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 16 hours 38 minutes ago

Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 17 hours 13 minutes ago

Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 17 hours 13 minutes ago

Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 18 hours 38 minutes ago

LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories

View all ACCESSWIRE

EQS Group

Published on 05/23/2026 at 16:30, 3 hours 8 minutes ago

HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 3 hours 41 minutes ago

EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 21 hours 33 minutes ago

Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 21 hours 33 minutes ago

Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 23 hours 47 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices

Les Echos

Published on 05/22/2026 at 19:35, 1 day ago

PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day 1 hour ago

Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day 1 hour ago

Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 6 hours ago

Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 6 hours ago

Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026

View all LES ECHOS COMFI WIRE